Skip to main content
Erschienen in:

06.09.2018 | Original Article

Clinical impact of abdominal fat distribution measured by 3-D computed tomography volumetry on post-transplant renal function in recipients after living kidney transplantation: a retrospective study

verfasst von: Yosuke Mitsui, Takuya Sadahira, Motoo Araki, Yuki Maruyama, Koichiro Wada, Ryuta Tanimoto, Yasuyuki Kobayashi, Masami Watanabe, Toyohiko Watanabe, Yasutomo Nasu

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Excessive visceral fat may decrease renal function because of metabolic derangements. The aim of this study was to evaluate the impact of abdominal fat distribution on renal function of recipients after kidney transplantation using the visceral adipose tissue (VAT)/subcutaneous adipose tissue (SAT) ratio.

Methods

Seventy-nine patients underwent living kidney transplantation from 2009 to 2017. Patients without a correct measurement of VAT and SAT, follow-up of < 6 months, or with kidney transplant rejection or a virus infection were excluded. VAT and SAT were calculated automatically by 3-D volume analyzer software in recipients prior to living kidney transplantation. Our primary aim was to identify abdominal fat distribution measured by CT associated with renal dysfunction (estimate glomerular filtration rate; eGFR < 45) at 6 month post renal transplantation in recipient.

Results

Fifty-eight living kidney recipients were included in this retrospective study: 30 for the high VAT/SAT ratio group; 28 for the VAT/SAT low group. Multiple logistic regression analysis showed the VAT/SAT ratio and pre-donor eGFR were associated with eGFR < 45 ml/min/1.73 m2. An increase in VAT/SAT ratio was associated independently with the incidence of decreased renal function.

Conclusion

This finding indicates that adipose tissue distribution is an important predictor of the outcome of living kidney transplantation in recipients.
Literatur
2.
Zurück zum Zitat Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients. JAMA. 1993;270:1339–43.CrossRefPubMed Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients. JAMA. 1993;270:1339–43.CrossRefPubMed
3.
Zurück zum Zitat Hart A, Smith JM, Skeans MA, Gustafson SK, Stewart DE, Cherikh WS, et al. 2014 annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: kidney. Am J Transplant. 2016;16:11–46.CrossRefPubMedPubMedCentral Hart A, Smith JM, Skeans MA, Gustafson SK, Stewart DE, Cherikh WS, et al. 2014 annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: kidney. Am J Transplant. 2016;16:11–46.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Wang JH, Skeans MA, Israni AK. Current status of kidney transplant outcomes: dying to survive. Adv Chronic Kidney Dis. 2016;23:281–6.CrossRefPubMed Wang JH, Skeans MA, Israni AK. Current status of kidney transplant outcomes: dying to survive. Adv Chronic Kidney Dis. 2016;23:281–6.CrossRefPubMed
5.
Zurück zum Zitat Gabriel MD. Handbook of kidney transplantation. 6th ed. Alphen aan den Rijn: Wolters Kluwer; 2017. pp. 306–8. Gabriel MD. Handbook of kidney transplantation. 6th ed. Alphen aan den Rijn: Wolters Kluwer; 2017. pp. 306–8.
6.
Zurück zum Zitat Hricik DE. Metabolic syndrome in kidney transplantation: management of risk factors. Clin J Am Soc Nephrol. 2011;6:1781–5.CrossRefPubMed Hricik DE. Metabolic syndrome in kidney transplantation: management of risk factors. Clin J Am Soc Nephrol. 2011;6:1781–5.CrossRefPubMed
7.
Zurück zum Zitat LaGuardia H, Zhang R. Obesity and metabolic syndrome in kidney transplantation. Curr Hypertens Rep. 2013;15:215–23.CrossRefPubMed LaGuardia H, Zhang R. Obesity and metabolic syndrome in kidney transplantation. Curr Hypertens Rep. 2013;15:215–23.CrossRefPubMed
8.
Zurück zum Zitat Alman AC, Smith SR, Eckel RH, Hokanson JE, Burkhardt BR, Sudini PR, et al. The ratio of pericardial to subcutaneous adipose tissues is associated with insulin resistance. Obesity. 2017;25:1284–91.CrossRefPubMed Alman AC, Smith SR, Eckel RH, Hokanson JE, Burkhardt BR, Sudini PR, et al. The ratio of pericardial to subcutaneous adipose tissues is associated with insulin resistance. Obesity. 2017;25:1284–91.CrossRefPubMed
9.
Zurück zum Zitat Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371:1131–41.CrossRefPubMed Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371:1131–41.CrossRefPubMed
10.
Zurück zum Zitat Rosenquist KJ, Pedley A, Massaro JM, Therkelsen KE, Murabito JM, Hoffmann U, et al. Visceral and subcutaneous fat quality and cardiometabolic risk. J Am Coll Cardiol Imaging. 2013;6:762–71.CrossRef Rosenquist KJ, Pedley A, Massaro JM, Therkelsen KE, Murabito JM, Hoffmann U, et al. Visceral and subcutaneous fat quality and cardiometabolic risk. J Am Coll Cardiol Imaging. 2013;6:762–71.CrossRef
11.
Zurück zum Zitat Abraham TM, Pedley A, Massaro JM, Hoffmann U, Fox CS. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 2015;132:1639–47.CrossRefPubMedPubMedCentral Abraham TM, Pedley A, Massaro JM, Hoffmann U, Fox CS. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 2015;132:1639–47.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat von Düring ME, Jenssen T, Bollerslev J, Asberg A, Godang K, Hartmann A. Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation. Clin Transplant. 2017;31:e12869.CrossRef von Düring ME, Jenssen T, Bollerslev J, Asberg A, Godang K, Hartmann A. Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation. Clin Transplant. 2017;31:e12869.CrossRef
13.
Zurück zum Zitat Ladeiras-Lopes R, Sampaio F, Bettencourt N, Fontes-Carvalho R, Ferreira N, Leite-Moreira A, Gama V. The ratio between visceral and subcutaneous abdominal fat assessed by computed tomography is an independent predictor of mortality and cardiac events. Rev Esp Cardiol. 2017;70:331–7.CrossRefPubMed Ladeiras-Lopes R, Sampaio F, Bettencourt N, Fontes-Carvalho R, Ferreira N, Leite-Moreira A, Gama V. The ratio between visceral and subcutaneous abdominal fat assessed by computed tomography is an independent predictor of mortality and cardiac events. Rev Esp Cardiol. 2017;70:331–7.CrossRefPubMed
14.
Zurück zum Zitat Lee HH, Kang SK, Yoon YE, Huh KH, Kim MS, Kim SI. Impact of the ratio of visceral to subcutaneous adipose tissue in donor nephrectomy patients. Transplant Proc. 2017;49:940–3.CrossRefPubMed Lee HH, Kang SK, Yoon YE, Huh KH, Kim MS, Kim SI. Impact of the ratio of visceral to subcutaneous adipose tissue in donor nephrectomy patients. Transplant Proc. 2017;49:940–3.CrossRefPubMed
15.
Zurück zum Zitat Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the Visceral Adiposity Index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis. 2011;10:183.CrossRefPubMedPubMedCentral Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the Visceral Adiposity Index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis. 2011;10:183.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (The VACATION-J study). Ann Med. 2012;44:82–92.CrossRefPubMed Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (The VACATION-J study). Ann Med. 2012;44:82–92.CrossRefPubMed
17.
Zurück zum Zitat Kanda Y. Investigation of the freely available easy-to-use software‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed Kanda Y. Investigation of the freely available easy-to-use software‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed
18.
Zurück zum Zitat Miyazaki Y, DeFronzo RA. Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol. 2009;8:44.CrossRefPubMedPubMedCentral Miyazaki Y, DeFronzo RA. Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol. 2009;8:44.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat He H, Ni Y, Chen J, Zhao Z, Zhong J, Liu D, et al. Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity. Transl Res. 2010;155:71–7.CrossRefPubMed He H, Ni Y, Chen J, Zhao Z, Zhong J, Liu D, et al. Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity. Transl Res. 2010;155:71–7.CrossRefPubMed
20.
Zurück zum Zitat Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55:2622–30.CrossRefPubMedPubMedCentral Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55:2622–30.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Mitsui Y, Sadahira T, Araki M, Wada K, Tanimoto R, Ariyoshi Y, et al. The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy. Clin Exp Nephrol. 2018;22:453–8.CrossRefPubMed Mitsui Y, Sadahira T, Araki M, Wada K, Tanimoto R, Ariyoshi Y, et al. The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy. Clin Exp Nephrol. 2018;22:453–8.CrossRefPubMed
22.
Zurück zum Zitat Lentine KL, Delos Santos R, Axelrod D, Schnitzler MA, Brennan DC, Tuttle-Newhall JE. Obesity and kidney transplant candidates: how big is too big for transplantation? Am J Nephrol. 2012;36:575–86.CrossRefPubMed Lentine KL, Delos Santos R, Axelrod D, Schnitzler MA, Brennan DC, Tuttle-Newhall JE. Obesity and kidney transplant candidates: how big is too big for transplantation? Am J Nephrol. 2012;36:575–86.CrossRefPubMed
23.
Zurück zum Zitat Minh-Ha T, Clarence EF, Kamyar KZ, Hirohito I. Kidney transplantation in obese patients. World J Transplant. 2016;6:135.CrossRef Minh-Ha T, Clarence EF, Kamyar KZ, Hirohito I. Kidney transplantation in obese patients. World J Transplant. 2016;6:135.CrossRef
24.
Zurück zum Zitat Bertram LK, Charles BC, Sundaram H, Hricik DE, Kerman RH, Roth D, et al. The evaluation of renal transplant candidates: clinical practice guidelines. Am J Transplant. 2001;2:3–95. Bertram LK, Charles BC, Sundaram H, Hricik DE, Kerman RH, Roth D, et al. The evaluation of renal transplant candidates: clinical practice guidelines. Am J Transplant. 2001;2:3–95.
25.
Zurück zum Zitat Montano-Loza AJ, Mazurak VC, Ebadi M, Meza-Junco J, Sawyer MB, Baracos VE, et al. Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant. Hepatology. 2018;67:914–23.CrossRefPubMed Montano-Loza AJ, Mazurak VC, Ebadi M, Meza-Junco J, Sawyer MB, Baracos VE, et al. Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant. Hepatology. 2018;67:914–23.CrossRefPubMed
26.
Zurück zum Zitat Jabłonowska-Lietz B, Wrzosek M, Włodarczyk M, Nowicka G. New indexes of body fat distribution, Visceral Adiposity Index, Body Adiposity Index, waist-to-height ratio, and metabolic disturbances in the obese. Kardiol Pol. 2017;75:1185–91.CrossRefPubMed Jabłonowska-Lietz B, Wrzosek M, Włodarczyk M, Nowicka G. New indexes of body fat distribution, Visceral Adiposity Index, Body Adiposity Index, waist-to-height ratio, and metabolic disturbances in the obese. Kardiol Pol. 2017;75:1185–91.CrossRefPubMed
27.
Zurück zum Zitat Raz I, Eldor R, Cernea S, Shafrir E. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab Res Rev. 2005;21:3–14.CrossRefPubMed Raz I, Eldor R, Cernea S, Shafrir E. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab Res Rev. 2005;21:3–14.CrossRefPubMed
28.
Zurück zum Zitat Bayer ND, Cochetti PT, Anil Kumar MS, Teal V, Huan Y, Doria C, et al. Association of metabolic syndrome with development of new-onset diabetes after transplantation. Transplantation. 2010;90:861–6.CrossRefPubMedPubMedCentral Bayer ND, Cochetti PT, Anil Kumar MS, Teal V, Huan Y, Doria C, et al. Association of metabolic syndrome with development of new-onset diabetes after transplantation. Transplantation. 2010;90:861–6.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat O’Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18:2758–65.CrossRefPubMed O’Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18:2758–65.CrossRefPubMed
30.
Zurück zum Zitat Chen KW, Wu MW, Chen Z, Tai BC, Goh YS, Lata R, et al. Compensatory hypertrophy after living donor nephrectomy. Transplant Proc. 2016;48:716–9.CrossRefPubMed Chen KW, Wu MW, Chen Z, Tai BC, Goh YS, Lata R, et al. Compensatory hypertrophy after living donor nephrectomy. Transplant Proc. 2016;48:716–9.CrossRefPubMed
31.
Zurück zum Zitat Pantik C, Cho YE, Hathaway D, Tolley E, Cashion A. Characterization of body composition and fat mass distribution 1 year after kidney transplantation. Prog Transplant. 2017;27:10–5.CrossRefPubMed Pantik C, Cho YE, Hathaway D, Tolley E, Cashion A. Characterization of body composition and fat mass distribution 1 year after kidney transplantation. Prog Transplant. 2017;27:10–5.CrossRefPubMed
32.
Zurück zum Zitat Kidney Disease. Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1. Kidney Disease. Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1.
Metadaten
Titel
Clinical impact of abdominal fat distribution measured by 3-D computed tomography volumetry on post-transplant renal function in recipients after living kidney transplantation: a retrospective study
verfasst von
Yosuke Mitsui
Takuya Sadahira
Motoo Araki
Yuki Maruyama
Koichiro Wada
Ryuta Tanimoto
Yasuyuki Kobayashi
Masami Watanabe
Toyohiko Watanabe
Yasutomo Nasu
Publikationsdatum
06.09.2018
Verlag
Springer Singapore
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2019
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1643-6

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Schützt das tägliche Glas Milch vor Darmkrebs?

Die Milch machts – sie bietet Frauen nach Daten einer großen Ernährungsanalyse den besten Darmkrebsschutz aller Lebensmittel, was am hohen Kalziumgehalt liegen dürfte. Am anderen Ende des Spektrums steht der Alkoholkonsum: Das Glas Wein am Abend ist eher ungünstig.

Vorsicht mit Glukokortikoiden bei Glomerulopathie

Auch niedrig dosierte Glukokortikoide zur Behandlung einer primären Glomerulopathie lassen offenbar die Infektionsgefahr steigen. In einer US-Studie hing das Risiko vor allem mit der kombinierten Anwendung von Immunsuppressiva zusammen.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.